Palivizumab, CAS 188039-54-5

Product Description: Palivizumab (MEDI 493), a humanized respiratory syncytial virus monoclonal antibody, reduces respiratory syncytial virus (RSV) infection[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics. 1998 Sep;102(3 Pt 1):531-7.

CAS Number: 188039-54-5

Molecular Weight: N/A

Compound Purity: 99.43

Research Area: Infection

Solubility: H2O

Target: RSV

• SKU: MEXHY-P9944-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P9944-10
• Green Labware: No
• Package Unit: 10 mg
• Quantity Unit: STK